The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance After a Single Dose Nevirapine (VIramune), Which is Part of ARV Prophylaxis for PMTCT in Moshi, TAnzania, and in Lusaka, Zambia (VITA2 Trial).

Trial Profile

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance After a Single Dose Nevirapine (VIramune), Which is Part of ARV Prophylaxis for PMTCT in Moshi, TAnzania, and in Lusaka, Zambia (VITA2 Trial).

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2013

At a glance

  • Drugs Nevirapine (Primary) ; Phenytoin (Primary) ; Lamivudine; Lamivudine/zidovudine; Zidovudine
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Acronyms VITA2
  • Most Recent Events

    • 17 Jul 2013 Primary endpoint 'Pharmacokinetic-parameters' has been met, according to the Journal of Antimicrobial Chemotherapy.
    • 17 Jul 2013 Primary endpoint 'Drug-elimination-half-life' has been met, according to the Journal of Antimicrobial Chemotherapy.
    • 17 Jul 2013 Primary endpoint 'Antiretroviral-resistance' has been met, according to the Journal of Antimicrobial Chemotherapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top